Are aminoglycosides essential in the treatment of continuous ambulatory peritoneal dialysis (CAPD) peritonitis?
D001419:Bacteria / Q000302:isolation & purification; D002981:Clindamycin / Q000627:therapeutic use*; D003023:Cloxacillin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use*; D008802:Mezlocillin / Q000627:therapeutic use*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology
D005839:Gentamicins; D002981:Clindamycin; D003023:Cloxacillin; D008802:Mezlocillin; D008712:Methicillin